Boston Scientific (BSX) Tops Q2 EPS by 2c; offers guidance
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $45.60 --0%
EPS Growth %: +10.7%
Financial Fact:
Research and development expenses: 232M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +10.7%
Financial Fact:
Research and development expenses: 232M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.75, $0.02 better than the analyst estimate of $0.73. Revenue for the quarter came in at $5.06 billion versus the consensus estimate of $4.89 billion.
GUIDANCE:
Boston Scientific sees FY2025 EPS of $2.95-$2.99, versus the consensus of $2.92.
Boston Scientific sees Q3 2025 EPS of $0.70-$0.72, versus the consensus of $0.70.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Cerebras Q1 EPS miss sends shares down 9% after-hours
- Darden Restaurants (DRI) PT Raised to $235 at Guggenheim
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
